![]() |
鲸腊异丙酯 |
|||
产品编号: | P0070834 | CAS号: | 64660-84-0 | |
分子式: | 分子量: | |||
EIENCS: |   |   |
鲸腊异丙酯 Cetyl Myristoleate CMO
Cetyl myristoleate is a compound used in dietary supplements that has anti-inflammatory, analgesic, and immune system modulation characteristics. Also known as CM8, the substance is an ester product of condensing myristoleic acid with cetyl alcohol and has a long efficacy cycle in the body. Cetyl myristoleate supplements are most commonly used to relieve the pain and mobility loss associated with ailments such as gout, osteoarthritis, rheumatoid arthritis, bursitis, and fibromyalgia. When used to treat joint ailments, CM8 works at the site of inflammation where it promotes cartilage growth and lubricates the damaged joint.
The anti-inflammatory and pain relieving characteristics of cetyl myristoleate came to light during the research of chemist Harry Diehl in the early 1960s. The focus of his research was the apparent total immunity mice and rats have to afflictions such as arthritis. During these studies, cetyl myristoleate was isolated as the common denominator. The results of his research were so positive that Diehl subsequently received three patents for cetyl myristoleate. Ironically the first human to benefit from CM8 was Harry Diehl himself when he successfully treated his own osteoarthritis.